loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Citalopram to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 409Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Gangwal Healthcare

02 5Nanjing Well Pharmaceutical

03 2Actylis

04 9BASF

05 4Finar

06 1Ideal Cures Pvt Ltd

07 2Kerry

08 2Nomisma Healthcare

09 1Sigachi Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Topical, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : GELLETS-P®

Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

Pharmacopoeia Ref : In-house

Technical Specs : NA

Grade : Oral

arrow

04

arrow
2024 ACI Convention
Not Confirmed

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ESPHERES EM

Applications : These spheres can be used as an inert base for modified release formulations promoting consistency and uniformity of release profile thus ensuring a uniform therapeutic response.

Pharmacopoeia Ref : Particle Sizes - #20 – #30, #30 – #40 and #40 – #60

Technical Specs : Not Available

Grade : Oral

arrow
blank

12

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : KOLLICOAT SR 30 D

Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specs : Not Available

Grade : Not Available

arrow
blank

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Soluplus

Excipient Details : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – poly...

Technical Specs :

Grade :

arrow

Brand : SOLUPLUS

Applications : Solubility and bioavailability enhancement, ideal for hot melt extrusion (HME)

Pharmacopoeia Ref : Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specs : Not Available

Grade : Not Available

arrow
blank